Bontia Bio
PrivateLast Round
Grant
Mar 26, 2025
Total Funding Raised
$1.14M
Company Overview
Bontia Bio operates in Healthcare & Life Sciences and is based in Wellington. Its latest recorded funding round was a Grant round in March 2025.
Bontia Bio is a biotechnology company that develops natural and sustainable antiparasitic compounds for animal health and agriculture using a proprietary synthetic biology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bontia Bio Comparables
Compare Bontia Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ASTRA Therapeutics | 76% | |
| Elanco | 72% | |
| Merck & Co., Inc. | 71% |
For institutional investors. Book with your work email.
Bontia Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 26, 2025 | ||||
| Seed | Mar 26, 2025 |
For institutional investors. Book with your work email.
Bontia Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Callaghan Innovation | Grant |
| Sprout Agritech | Seed |
| Booster Innovation Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2025
$430K raised from Callaghan Innovation.
- Mar 26, 2025
$710K round led by Sprout Agritech.
For institutional investors. Book with your work email.
Bontia Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bontia Bio's valuation, stock price, and market status.
Is Bontia Bio a public or private company?
Bontia Bio is a private company.
What is the current stock price of Bontia Bio?
Bontia Bio is a private company, so its shares have no public market price. Caplight tracks Bontia Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bontia Bio worth (valuation)?
Valuation information for Bontia Bio is not publicly available.
Can I buy Bontia Bio stock?
Bontia Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bontia Bio's last funding round?
Bontia Bio's most recent funding round was Grant on March 26, 2025.
Who are the main investors in Bontia Bio?
Key investors in Bontia Bio include Sprout Agritech.
Will Bontia Bio IPO soon?
No public IPO plans have been announced for Bontia Bio.
How can I track Bontia Bio secondary market activity?
Caplight tracks bids, offers, and trades in Bontia Bio's shares on secondary markets.